Escalating Tensions in Congo: Hospital Attack Highlights Ebola Containment Challenges The security situation in eastern Congo has reached a critical juncture following a violent incident at the Monbgwalu General Hospital. …
Tag:
Health care industry
-
-
Supply Chain Volatility: How the Strait of Hormuz Crisis is Pressuring U.S. Manufacturers For many U.S. Businesses, the Strait of Hormuz was once a distant geographic concern. Today, that narrow …
-
Eli Lilly Accuses Pentecostal Church Leaders in $200M+ Trulicity Rebate Fraud Scheme By Dr. Natalie Singh | Health Editor | May 20, 2026 Eli Lilly and Company has filed a …
-
TrumpRx Expands: Platform Adds Generic Drugs and New Pharmacy Tools The Trump administration is scaling its direct-to-consumer drug pricing platform, TrumpRx.gov, with a significant expansion of its offerings. On Monday, …
-
UnitedHealth Group Beats Q1 2026 Estimates, Raises Profit Outlook UnitedHealth Group reported first-quarter earnings that exceeded Wall Street expectations for both revenue and earnings per share on Tuesday, April 21, …
-
Pfizer to Pursue Lyme Disease Vaccine Approval Despite Late-Stage Trial Setback Pfizer announced on Monday it will seek regulatory approval for its investigational Lyme disease vaccine, despite the fact that …
-
The Rising Cost of Menstrual Products and Consumer Response Inflation and evolving tariff policies are impacting household budgets, and one often-overlooked area of increased expense is menstrual products. Despite declining …
-
GLP-1 Drugs Reshape Restaurant and Food Industries The rising adoption of GLP-1 receptor agonist medications, initially designed for managing type 2 diabetes, is significantly impacting the restaurant and food industries, …
-
Lilly’s Retatrutide Shows Promise in Type 2 Diabetes Trial, Delivering Significant Weight Loss Eli Lilly and Company announced positive topline results from the TRANSCEND-T2D-1 Phase 3 clinical trial evaluating retatrutide, …
-
Generic Ozempic and Wegovy Could Cost as Little as $3 a Month, Study Finds Generic versions of Novo Nordisk’s blockbuster drugs Ozempic and Wegovy could be available for under $3 …